Top Markets
Coin of the day
Artrya Limited Artrya Limited

Artrya Limited

AYA
Rank in Stocks #13456
Artrya Limited is a medical technology firm that harnesses artificial... Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application. Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in 2018, the company is headquartered in West Perth, Australia.
Share Price
$2.99
Market Cap
$487.33M
Change (1 day)
-10.74%
Change (1 year)
114.71%
Country
AU
Trade Artrya Limited (AYA)

Category

Earnings for Artrya Limited (AYA)
Earnings in 2026 TTM: 0
According to Artrya Limited latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Artrya Limited from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors